MCM
CNMD icon

Moore Capital Management’s CONMED CNMD Stock Holding History

Moore Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$869K Hold
24,579
– – 0.02% 383
2025
Q4 		$998K Buy
24,579
+4,945
+25% +$215K 0.01% 459
2025
Q3 		$923K Buy
19,634
+6,630
+51% +$344K 0.01% 438
2025
Q2 		$677K Buy
+13,004
New +$714K 0.01% 409

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Moore Capital Management's CNMD Position: Q1 2026 in Review

Moore Capital Management held its CONMED (CNMD) position steady in Q1 2026 at 24,579 shares worth $869K. The position accounts for 0.02% of the portfolio, ranked #383.

Moore Capital Management first reported a position in CNMD in Q2 2025 and has held it in 4 quarters since. The position peaked at $998K in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Moore Capital Management held 24,579 shares of CONMED worth $869K as of Q1 2026.
  • Moore Capital Management left its CONMED share count unchanged in Q1 2026.
  • CONMED made up 0.02% of Moore Capital Management's portfolio in Q1 2026, its #383 holding.
  • Moore Capital Management first reported a position in CONMED in Q2 2025 and has held it in 4 quarters since.
  • Moore Capital Management's CONMED position peaked at $998K in Q4 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.